• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中的微小RNA与突触功能障碍

MicroRNAs and synaptic dysfunction in Parkinson's disease.

作者信息

Ogwo Morgan N, Sharma Bhupender, Goyal Gunjan, Lakshmanaswamy Rajkumar, Kumar Subodh

机构信息

Center of Emphasis in Neuroscience, Department of Molecular and Translational Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, USA.

Center of Emphasis in Cancer, Department of Molecular and Translational Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, USA.

出版信息

Mol Ther Nucleic Acids. 2025 Aug 12;36(3):102673. doi: 10.1016/j.omtn.2025.102673. eCollection 2025 Sep 9.

DOI:10.1016/j.omtn.2025.102673
PMID:40917892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12408229/
Abstract

Parkinson's disease (PD) is a debilitating neurodegenerative condition. Synaptic dysfunctions are associated with the onset and progressive neurodegeneration exhibited in PD. Healthy, active synapses are a prerequisite for non-pathological neurotransmission. When neurotransmission becomes pathological, such as observed in neurodegenerative conditions like PD, the biomolecules found in and around such synapses need distinctive investigation. MicroRNAs (miRNAs) found in neuronal subcellular compartments, such as dendrites, pre-synaptic boutons, and synaptic vesicles, have been garnering attention in neurogenerative diseases. MiRNAs that modulate synaptic activity and synapse function are called synaptic miRNAs. Several miRNAs have been identified that regulate key synaptic proteins; however, information about synaptic miRNAs is largely unknown in PD. In this review, we focused on the most promising synaptic miRNAs, those that are critical for normal synapse function and play a crucial role in PD pathology. We also discussed the synaptic miRNA's interplay with PD-associated synaptic dysfunction. Investigating further how synaptic miRNAs impacts PD pathogenesis may uncover novel etiological information and potential pathways for treatments and a cure for PD.

摘要

帕金森病(PD)是一种使人衰弱的神经退行性疾病。突触功能障碍与PD中出现的发病和进行性神经退行性变有关。健康、活跃的突触是正常神经传递的先决条件。当神经传递变得病理性时,如在PD等神经退行性疾病中观察到的那样,在这些突触及其周围发现的生物分子需要进行特殊研究。在神经元亚细胞区室(如树突、突触前终扣和突触小泡)中发现的微小RNA(miRNA)在神经退行性疾病中受到了关注。调节突触活动和突触功能的miRNA被称为突触miRNA。已经鉴定出几种调节关键突触蛋白的miRNA;然而,在PD中,关于突触miRNA的信息大多未知。在这篇综述中,我们聚焦于最有前景的突触miRNA,即那些对正常突触功能至关重要且在PD病理过程中起关键作用的miRNA。我们还讨论了突触miRNA与PD相关突触功能障碍的相互作用。进一步研究突触miRNA如何影响PD发病机制可能会揭示新的病因信息以及治疗和治愈PD的潜在途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ee/12408229/a6df9c3bba6c/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ee/12408229/f1a1f36db169/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ee/12408229/dd90d3e06c4f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ee/12408229/067b0255710c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ee/12408229/2fb82d77a390/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ee/12408229/a6df9c3bba6c/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ee/12408229/f1a1f36db169/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ee/12408229/dd90d3e06c4f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ee/12408229/067b0255710c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ee/12408229/2fb82d77a390/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78ee/12408229/a6df9c3bba6c/gr4.jpg

相似文献

1
MicroRNAs and synaptic dysfunction in Parkinson's disease.帕金森病中的微小RNA与突触功能障碍
Mol Ther Nucleic Acids. 2025 Aug 12;36(3):102673. doi: 10.1016/j.omtn.2025.102673. eCollection 2025 Sep 9.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Short-Term Memory Impairment短期记忆障碍
4
Tissue Factor and Its Cerebrospinal Fluid Protein Profiles in Parkinson's Disease.组织因子及其在帕金森病中的脑脊液蛋白谱。
J Parkinsons Dis. 2024;14(7):1405-1416. doi: 10.3233/JPD-240115.
5
Reduced expression of gene in cortex glia causes dopaminergic cell death.皮层神经胶质细胞中基因表达的降低会导致多巴胺能细胞死亡。
J Parkinsons Dis. 2025 Aug;15(5):957-969. doi: 10.1177/1877718X251349407. Epub 2025 Jun 16.
6
SGLT2 inhibitors vs. metformin for Parkinson's disease risk reduction in type 2 diabetes.钠-葡萄糖协同转运蛋白2抑制剂与二甲双胍对2型糖尿病患者帕金森病风险的降低作用比较
J Parkinsons Dis. 2025 Jul 17:1877718X251359391. doi: 10.1177/1877718X251359391.
7
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
8
Aspects of Genetic Diversity, Host Specificity and Public Health Significance of Single-Celled Intestinal Parasites Commonly Observed in Humans and Mostly Referred to as 'Non-Pathogenic'.人类常见且大多被称为“非致病性”的单细胞肠道寄生虫的遗传多样性、宿主特异性及公共卫生意义
APMIS. 2025 Sep;133(9):e70036. doi: 10.1111/apm.70036.
9
SynNeurGe: The road ahead for a biological definition of Parkinson's disease.SynNeurGe:帕金森病生物学定义的未来之路。
J Parkinsons Dis. 2024 Dec 8:1877718X241298194. doi: 10.1177/1877718X241298194.
10
Proposed mechanisms of neuroprotection for nicotine in Parkinson's disease.帕金森病中尼古丁神经保护的潜在机制。
J Parkinsons Dis. 2025 Jul 10:1877718X251355112. doi: 10.1177/1877718X251355112.

本文引用的文献

1
Differential Effects of Paraquat, Rotenone, and MPTP on Cellular Bioenergetics of Undifferentiated and Differentiated Human Neuroblastoma Cells.百草枯、鱼藤酮和 1-甲基-4-苯基-1,2,3,6-四氢吡啶对未分化和分化的人神经母细胞瘤细胞的细胞生物能量学的差异影响
Brain Sci. 2023 Dec 14;13(12):1717. doi: 10.3390/brainsci13121717.
2
ApoE-functionalization of nanoparticles for targeted brain delivery-a feasible method for polyplexes?载脂蛋白 E 功能化纳米颗粒用于靶向脑递送——多聚物载体的一种可行方法?
Drug Deliv Transl Res. 2024 Jun;14(6):1660-1677. doi: 10.1007/s13346-023-01482-w. Epub 2023 Dec 12.
3
Mitochondrial dysfunction in Parkinson's disease - a key disease hallmark with therapeutic potential.
帕金森病中的线粒体功能障碍——具有治疗潜力的关键疾病标志。
Mol Neurodegener. 2023 Nov 11;18(1):83. doi: 10.1186/s13024-023-00676-7.
4
Gender differences in microRNA expression in levodopa-naive PD patients.左旋多巴初治 PD 患者中微小 RNA 表达的性别差异。
J Neurol. 2023 Jul;270(7):3574-3582. doi: 10.1007/s00415-023-11707-0. Epub 2023 Apr 13.
5
DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson's disease.DOPAL引发帕金森病中α-突触核蛋白依赖性的蛋白稳态受损和神经元突起退化。
NPJ Parkinsons Dis. 2023 Mar 25;9(1):42. doi: 10.1038/s41531-023-00485-1.
6
miR-101a-3p Impairs Synaptic Plasticity and Contributes to Synucleinopathy.miR-101a-3p 损害突触可塑性并导致突触核蛋白病。
J Parkinsons Dis. 2023;13(2):179-196. doi: 10.3233/JPD-225055.
7
R1441C and G2019S LRRK2 knockin mice have distinct striatal molecular, physiological, and behavioral alterations.R1441C 和 G2019S LRRK2 基因敲入小鼠具有不同的纹状体分子、生理和行为改变。
Commun Biol. 2022 Nov 10;5(1):1211. doi: 10.1038/s42003-022-04136-8.
8
MiR-130/SNAP-25 axis regulate presynaptic alteration in anterior cingulate cortex involved in lead induced attention deficits.miR-130/SNAP-25 轴调控前额叶皮质中铅诱导的注意缺陷相关的突触前改变。
J Hazard Mater. 2023 Feb 5;443(Pt B):130249. doi: 10.1016/j.jhazmat.2022.130249. Epub 2022 Oct 25.
9
MiR-29a inhibits MPP + - Induced cell death and inflammation in Parkinson's disease model in vitro by potential targeting of MAVS.miR-29a 通过潜在靶向 MAVS 抑制帕金森病模型中 MPP+诱导的细胞死亡和炎症。
Eur J Pharmacol. 2022 Nov 5;934:175302. doi: 10.1016/j.ejphar.2022.175302. Epub 2022 Sep 26.
10
Differential microRNA expression analyses across two brain regions in Alzheimer's disease.阿尔茨海默病两个脑区差异 microRNA 表达分析。
Transl Psychiatry. 2022 Aug 29;12(1):352. doi: 10.1038/s41398-022-02108-4.